(Press-News.org)
Our intestines are home to trillions of microorganisms that produce substances capable of regulating all the body’s organs via the bloodstream and the gut’s nervous system. Yet, only little is known about the effects of most of the bacteria that make up our microbiome. Now, an international team of scientists led by the University of Copenhagen has identified a common specific bacterial strain that may open the door to an entirely new class of therapeutics.
This bacterium produces two proteins that partly resemble the hormone irisin. Irisin is released by muscles during physical activity and plays a role in fat metabolism.
The newly discovered signaling proteins, named RORDEP1 and RORDEP2, influence the body’s hormonal balance and affect weight, bone density, and blood sugar levels.
“We found that the number of RORDEP-producing bacteria can vary by up to 100,000 times between individuals, and that people with high levels of these bacteria tend to be leaner,” says Yong Fan, Assistant Professor at the Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen and lead author of the study, which has just been published in the prestigious journal Nature Microbiology.
Regulates Body Weight and Blood Sugar
In the study, the researchers describe how RORDEP-proteins increase the body’s own production of hormones such as GLP-1 and PYY, which help regulate appetite and blood sugar, as well as insulin, which is essential for maintaining stable blood sugar levels. At the same time, they suppress another hormone, GIP, which can contribute to weight gain. RORDEP-proteins also directly enhance fat burning.
“In experiments with rats and mice that received either RORDEP-producing gut bacteria or the RORDEP proteins themselves, we observed reduced weight gain and lower blood sugar levels, along with increased bone density. What’s exciting is that this is the first time we’ve mapped gut bacteria that alter our hormonal balance,” says Yong Fan.
A Paradigm Shift in Treating Chronic Diseases
Research into the role of gut bacteria in human health has led the University of Copenhagen researchers to establish the biotech company GutCRINE already two years ago, with financial support from the university.
The first clinical trials are now underway. In one study, healthy participants are given live bacteria that produce RORDEPs to examine how they affect human biology. Another trial is testing the effects of the RORDEP1 protein.
“We’re now translating our basic research into human studies to explore whether RORDEP-producing bacteria or the RORDEP proteins - either in their natural or chemically modified form - can serve as the foundation for a new class of biological drugs known as pharmabiotics,” says Professor Oluf Pedersen from the University of Copenhagen, project leader and senior author of the new study. He adds:
“Looking 10 to 15 years ahead, our goal is to test the potential of RORDEP-producing bacteria for both prevention and treatment. We want to investigate whether they can function as a second-generation probiotic - used as a dietary supplement to prevent common chronic diseases - and whether RORDEP-proteins in modified forms can be developed into future medicines for cardiovascular disease, obesity, diabetes, and osteoporosis.”
The research was conducted in collaboration with scientists from the University of Copenhagen, Herlev-Gentofte Hospital, Zealand University Hospital, Novo Nordisk A/S, the Technical University of Denmark, Steno Diabetes Center, and Chongqing Medical University. Read the study Polypeptides synthesized by common bacteria in the human gut improve rodent metabolism here.
END
For decades, scientists and conservationists have been using aboveground plant biodiversity as a metric for conserving ecosystems. Now a new study finds that there is a major mismatch between aboveground plant diversity and Earth’s underground fungal biodiversity.
A new analysis published in Nature Communications on July 31 focused on the biodiversity mismatches between aboveground vegetation and mycorrhizal fungi – a group of underground fungi that form symbiotic relationships with the roots of 90% of land plants. These fungi help regulate the climate and global nutrient cycles, ...
The European Molecular Biology Laboratory (EMBL) has long been a pioneer in developing and applying Artificial Intelligence (AI) to advance genomics, structural biology, and drug discovery. One of the standout examples is AlphaFold – developed by Google DeepMind and trained on data provided by EMBL-EBI and collaborators – which has revolutionised protein structure prediction. With EMBL-EBI’s support, AlphaFold2 predictions were made freely available to researchers worldwide.
Alongside its major contributions to AI in structural biology, EMBL is also leading the way in applying AI to all types of biological data analysis and scientific research, including ...
By Beth Miller
Nature is often the best model for science. For nearly a century, scientists have been trying to recreate the ability of some mammals and birds to survive extreme environmental conditions for brief or extended periods by going into torpor, when their body temperature and metabolic rate drop, allowing them to preserve energy and heat.
Taking inspiration from nature, Hong Chen, professor of biomedical engineering in the McKelvey School of Engineering and of neurosurgery at WashU Medicine, and an interdisciplinary team induced a reversible torpor-like state in mice by using focused ultrasound to stimulate the ...
A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates.
Researchers at UT Southwestern Medical Centre used ChatGPT to assess whether patients were eligible to take part in clinical trials and were able to identify suitable candidates within minutes.
Clinical trials, which test new medications and procedures on the public, are vital for developing and validating new treatments. But many trials struggle to enrol enough participants. According to a recent study, up to 20% of National Cancer Institute (NCI)-affiliated ...
Cambridge scientists have developed and tested a new drug in mice that has the potential to reduce damage to the brain when blood flow is restored following a stroke.
As many as one in four people will have a stroke during their lifetime. This is when a blood clot prevents oxygen from reaching a part of the brain. The first few hours following a stroke are crucial – the blood clot needs to be removed quickly so that the oxygen supply to the brain can be restored; otherwise, the brain tissue begins to die.
Currently, the outcome for stroke patients receiving even the best available ...
In south-east Asia, betel nut chewing has been practiced since antiquity. The plants contain compounds that enhance the consumer’s alertness, energy, euphoria, and relaxation. Although the practice is becoming less common in modern times, it has been deeply embedded in social and cultural traditions for thousands of years. Chewing betel nuts typically results in dark, reddish-brown to black stained teeth.
Yet, teeth without staining may not mean that people didn’t chew betel nuts. Now, using a new method, an international team ...
The Energy & Environment Materials Research Division of the Korea Institute of Materials Science (KIMS), led by Dr. Dong-chan Lim and Dr. So-yeon Kim, has developed a highly durable flexible perovskite solar cell material and fabrication process that remains stable even under high humidity conditions. This breakthrough enables the production of high-efficiency solar cells in ambient air without the need for expensive equipment, offering the potential for significant cost reductions in manufacturing.
Perovskite has attracted attention as a next-generation material capable of replacing conventional silicon solar cells due to its excellent light absorption, ...
A new study has found that, among women with a high desire to avoid becoming pregnant, those who drank heavily had a 50% higher risk of becoming pregnant than those who drank moderately or not at all. In contrast, participants who used cannabis were no more likely to have an undesired pregnancy than participants who did not use cannabis.
From a larger sample of over 2,000 non-pregnant women aged 15-34, researchers identified a subgroup of 936 who didn't want to get pregnant. Within that subgroup, ...
A new study published today in the scientific journal Addiction has found that young adults in the US do not ‘titrate’ when using strong cannabis. In other words, they do not use less cannabis to compensate for the stronger potency. In fact, it’s the opposite: young adults who report using strong cannabis also typically use it more frequently and in higher quantities than young adults who use weaker forms of the drug.
This study surveyed over 400 young adults in California USA who had used cannabis in the past month. They were asked to describe the strength of their typical cannabis product using a THC potency scale of 0 (no THC) to 5 (very high THC concentration). ...
Kyoto, Japan -- Black holes embody the ultimate abyss. They are the most powerful sources of gravity in the universe, capable of dramatically distorting space and time around them. When disturbed, they begin to "ring" in a distinctive pattern known as quasinormal modes: ripples in space-time that produce detectable gravitational waves.
In events like black hole mergers, these waves can be strong enough to detect from Earth, offering a unique opportunity to measure a black hole's mass and shape. However, precise calculation of these vibrations through theoretical methods ...
